Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome

Am J Obstet Gynecol. 2009 Jun;200(6):636.e1-6. doi: 10.1016/j.ajog.2008.12.046. Epub 2009 Feb 28.

Abstract

Objective: The purpose of this research was to study factors that are involved in centromeric hypomethylation in the pathogenesis of Down syndrome (DS).

Study design: This was a case-control study to evaluate the association between methyltetrahydrofolate reductase (MTHFR) C677T and methionine synthetase-reductase (MTRR) A66G polymorphisms and the risk of DS; we compared mothers in Italy who had children with DS and matched control subjects.

Results: Seventy-four cases of DS caused by an error in maternal meiosis were compared with 184 matched control subjects. The frequencies of the MTHFR C677T polymorphism were similar between the 2 groups. As regards the MTRR A66G polymorphism, the presence of the mutated G allele either in the heterozygous or homozygous form was significantly more common among mothers of children with DS than among control subjects (odds ratio, 2.21; 95% CI, 1.11-4.40).

Conclusion: In a population with a high prevalence of the mutated T allele, maternal MTRR A66G, but not MTHFR, polymorphisms are associated with Down syndrome.

MeSH terms

  • Adult
  • Case-Control Studies
  • Child
  • Down Syndrome / genetics*
  • Female
  • Ferredoxin-NADP Reductase / genetics*
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Mothers
  • Polymorphism, Genetic*
  • Risk Factors
  • Young Adult

Substances

  • methionine synthase reductase
  • Ferredoxin-NADP Reductase
  • Methylenetetrahydrofolate Reductase (NADPH2)